2018Unpublished venueRequires access

Description and analysis of the Alpha 1 antitrypsin deficitary genotypes in the southwest area of Galicia (Spain)

Ramon Antonio Tubio Perez, María Torres Durán, Milagros Blanco Perez, Cristina Ramos‐Hernández, Cecilia Mouronte Roibás, David Dacal-Rivas, Victoria Arnalich Montiel, Alberto Fernández‐Villar

Open publisher page 0 citations

Abstract

Introduction: Alpha 1 antitrypsin deficiency (AATD) is a genetic condition that predisposes to the development of pulmonary emphysema and liver disease. Objectives: The aim of this study was to assess the characteristics of patients with AATD and the distribution of genotypes analyzed in the CHUVI Genetics Laboratory. Methods: Retrospective analysis of patients who underwent AAT levels determination between 2012-2017. Analysis of deficient alleles, frequency and distribution. Genetic study was performed in those cases with serum concentration of Alpha-1 antitrypsin ≤ 120 mg/dl and RCP ≤ 3 mg/dl (according to laboratory protocol). Results: 491 patients. Pi*ZZ genotype was found in 18 (3.7%), Pi*SZ in 100 (20.4%), Pi*MZ in 143 (29.1%), Pi*SS in 26 (5.3%) and No-Sno-Z in 174 (35,4%): 14 rare or null variants (6 Mmalton/M, 2 Mmalton/Z, 1 Mmalton/S, 1 S/QOurem, 1 S/MHerleen, 1 I/Z, 1 PLowell/S and 1 PLowell/Z), which were diagnosed by sequencing the gene. Serum levels were ZZ: 32 mg/dl (20-64), SZ: 66 mg/dl (42-120), MZ: 83 mg/dl (21-147), SS: 88 mg/dl (56-127) and No-S No-Z: 101 mg/dl (18-390). Conclusions: Genotypes associated with severe deficiency showed worse pulmonary function. Galicia is an area of relatively high prevalence of AATD, so this diagnostic possibility should be considered in the study of patients with diseases related to this genetic condition and in relatives of affected individuals.

About this research paper

What this paper is about

Introduction: Alpha 1 antitrypsin deficiency (AATD) is a genetic condition that predisposes to the development of pulmonary emphysema and liver disease. Objectives: The aim of this study was to assess the characteristics of patients with AATD and the distribution of genotypes analyzed in the CHUVI Genetics Laboratory. Methods: Retrospective analysis of patients who underwent AAT levels determination between 2012-2017. Analysis of deficient alleles, frequency and distribution. Genetic study was performed in those cases with serum concentration of Alpha-1 antitrypsin ≤ 120 mg/dl and RCP ≤ 3 mg/dl (according to laboratory protocol). Results: 491 patients. Pi*ZZ genotype was found in 18 (3.7%), Pi*SZ in 100 (20.4%), Pi*MZ in 143 (29.1%), Pi*SS in 26 (5.3%) and No-Sno-Z in 174 (35,4%): 14 rare or null variants (6 Mmalton/M, 2 Mmalton/Z, 1 Mmalton/S, 1 S/QOurem, 1 S/MHerleen, 1 I/Z, 1 PLowell/S and 1 PLowell/Z), which were diagnosed by sequencing the gene. Serum levels were ZZ: 32 mg/dl (20-64), SZ: 66 mg/dl (42-120), MZ: 83 mg/dl (21-147), SS: 88 mg/dl (56-127) and No-S No-Z: 101 mg/dl (18-390). Conclusions: Genotypes associated with severe deficiency showed worse pulmonary function. Galicia is an area of relatively high prevalence of AATD, so this diagnostic possibility should be considered in the study of patients with diseases related to this genetic condition and in relatives of affected individuals.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Introduction: Alpha 1 antitrypsin deficiency (AATD) is a genetic condition that predisposes to the development of pulmonary emphysema and liver disease. Objectives: The aim of this study was to assess the characteristics of patients with AATD and the distribution of genotypes analyzed in the CHUVI Genetics Laboratory. Methods: Retrospective analysis of patients who underwent AAT levels determination between 2012-2017. Analysis of deficient alleles, frequency and distribution. Genetic study was performed in those cases with serum concentration of Alpha-1 antitrypsin ≤ 120 mg/dl and RCP ≤ 3 mg/dl (according to laboratory protocol). Results: 491 patients. Pi*ZZ genotype was found in 18 (3.7%), Pi*SZ in 100 (20.4%), Pi*MZ in 143 (29.1%), Pi*SS in 26 (5.3%) and No-Sno-Z in 174 (35,4%): 14 rare or null variants (6 Mmalton/M, 2 Mmalton/Z, 1 Mmalton/S, 1 S/QOurem, 1 S/MHerleen, 1 I/Z, 1 PLowell/S and 1 PLowell/Z), which were diagnosed by sequencing the gene. Serum levels were ZZ: 32 mg/dl (20-64), SZ: 66 mg/dl (42-120), MZ: 83 mg/dl (21-147), SS: 88 mg/dl (56-127) and No-S No-Z: 101 mg/dl (18-390). Conclusions: Genotypes associated with severe deficiency showed worse pulmonary function. Galicia is an area of relatively high prevalence of AATD, so this diagnostic possibility should be considered in the study of patients with diseases related to this genetic condition and in relatives of affected individuals.

Key concepts: Medicine, Genotype, Gastroenterology, Alpha 1-antitrypsin deficiency, Internal medicine, Group B, Allele, Retrospective cohort study

Related papers

Back to paper searchBrowse research topicsOriginal source
Description and analysis of the Alpha 1 antitrypsin deficitary genotypes in the southwest area of Galicia (Spain) — Research Paper | ScholarLens